Algert Global LLC grew its holdings in shares of agilon health, inc. (NYSE:AGL - Free Report) by 1,042.7% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,108,687 shares of the company's stock after acquiring an additional 1,924,157 shares during the quarter. Algert Global LLC owned 0.51% of agilon health worth $4,007,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in AGL. Capital International Investors boosted its stake in shares of agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock valued at $42,431,000 after purchasing an additional 9,346,295 shares during the period. Charles Schwab Investment Management Inc. grew its holdings in agilon health by 49.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock worth $8,629,000 after acquiring an additional 1,498,524 shares during the last quarter. JPMorgan Chase & Co. raised its position in agilon health by 326.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company's stock valued at $5,563,000 after purchasing an additional 1,083,492 shares during the last quarter. Susquehanna Fundamental Investments LLC purchased a new stake in agilon health in the 4th quarter worth approximately $1,616,000. Finally, Alberta Investment Management Corp bought a new stake in shares of agilon health in the 4th quarter worth approximately $1,564,000.
Analysts Set New Price Targets
A number of brokerages recently commented on AGL. Sanford C. Bernstein raised agilon health from a "market perform" rating to an "outperform" rating and raised their price target for the stock from $3.30 to $8.50 in a research note on Tuesday, April 8th. Barclays raised their target price on shares of agilon health from $2.00 to $3.00 and gave the stock an "underweight" rating in a research report on Thursday. The Goldman Sachs Group boosted their price target on shares of agilon health from $2.50 to $5.00 and gave the company a "neutral" rating in a research report on Thursday. JMP Securities restated a "market perform" rating on shares of agilon health in a report on Monday, April 28th. Finally, Stifel Nicolaus upped their target price on agilon health from $2.00 to $3.00 and gave the stock a "hold" rating in a report on Wednesday, February 26th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $4.89.
View Our Latest Report on AGL
agilon health Trading Up 1.9%
Shares of AGL stock traded up $0.06 on Monday, reaching $2.95. 1,089,920 shares of the company's stock were exchanged, compared to its average volume of 5,855,549. The company's fifty day simple moving average is $4.27 and its 200 day simple moving average is $3.19. agilon health, inc. has a 52 week low of $1.50 and a 52 week high of $7.73. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $1.22 billion, a PE ratio of -3.13 and a beta of 0.38.
agilon health (NYSE:AGL - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of ($0.01) by $0.04. The business had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.50 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. The business's revenue for the quarter was down 4.5% compared to the same quarter last year. During the same period last year, the company earned ($0.02) earnings per share. As a group, analysts forecast that agilon health, inc. will post -0.59 EPS for the current year.
agilon health Profile
(
Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories

Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.